Abstract
The US Food and Drug Administration's current standards require that new diabetes medications demonstrate cardiovascular safety in large, long-term trials. New drugs that have been assessed in such trials are changing the management of type 2 diabetes.
Original language | English (US) |
---|---|
Pages (from-to) | 759-767 |
Number of pages | 9 |
Journal | Cleveland Clinic journal of medicine |
Volume | 84 |
Issue number | 10 |
DOIs | |
State | Published - 2017 |
ASJC Scopus subject areas
- General Medicine